The U.S. patent system is not in a good place today. Patents are worth substantially less than they were a decade ago, patents are much easier to challenge thanks to the high kill rate of the Patent Trial and Appeal Board (PTAB), and some of America’s most innovative industries face questions as to whether their core innovations can be protected at all in the United States. Inventions in the life sciences sector and software have been hardest hit, and while many of those inventions are not protectable in the United States they can be patented in China, Europe, Canada, Australia and elsewhere.
